EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Generation of noncanonical fumagillin derivatives with a twisted cyclohexane conformation through engineered biosynthesis

Yuta Tsunematsu iD, Yuji Ogata, Kanji Niwa, Namiko Ogata, Seiki Kobayashi, Michio Sato, Takuma Matsushita, Ryota Shizu, Kouichi Yoshinari iD, Mihoko Mori, Yumiko Saito-Nakano, Tomoyoshi Nozaki und 1 weitere

Bioscience, Biotechnology, and Biochemistry · 2025

DOI: 10.1093/bbb/zbaf091 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioscience, Biotechnology, and Biochemistry, 2025. Verfasst von Yuta Tsunematsu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Biosciences, Graduate School of Bioagricultural Sciences, Nagoya University, Aichi, Japan. Hauptthemen laut MEDLINE: Cyclohexanes, Sesquiterpenes, Metabolic Engineering. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fumagillin-class natural products, known as methionine aminopeptidase 2 inhibitors, have been explored as drug candidates for cancer, obesity, and infectious diseases such as amoebiasis. However, clinical development has been hindered by adverse effects. Here, we identified 2 fumagillin analogues via engineered biosynthesis in Saccharomyces cerevisiae, coupled with metabolomics and activity-guided isolation. Spectroscopic analysis revealed unique 6-oxabicyclo[3.2.1]octane scaffolds that are unprecedented among naturally occurring fumagillins. The compounds exhibited selective antiamoebic activity without cytotoxicity to human lung cells. Stereochemical and computational studies suggested that the unique bicyclic system arises from a twist-boat conformer that enables intramolecular ether formation. These findings demonstrate that biosynthetic pathway engineering can expand the chemical diversity of fumagillin-related molecules and provide new leads for antiparasitic drug discovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CyclohexanesSesquiterpenesMetabolic EngineeringHumansSaccharomyces cerevisiaePolycyclic SesquiterpenesMolecular ConformationAminopeptidasesFatty Acids, UnsaturatedMetalloendopeptidases

Stichwörter der Autor:innen

antiamoebiasisengineered biosynthesisfumagillinnatural productsstructure elucidation

Substanzen

fumagillinCyclohexanesPolycyclic SesquiterpenesSesquiterpenesCyclohexanemethionine aminopeptidase 2AminopeptidasesFatty Acids, UnsaturatedMetalloendopeptidases

Autor:innen und Institutionen

  • Department of Applied Biosciences, Graduate School of Bioagricultural Sciences, Nagoya University, Aichi, Japan.
  • School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.
  • Science and Innovation Center, Mitsubishi Chemical Corporation, Kanagawa, Japan.
  • Department of Parasitology, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
  • Graduate School of Agriculture, Tokyo University of Agriculture and Technology, Tokyo, Japan.
  • Department of Biomedical Chemistry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

ORCID-Profile: Yuta Tsunematsu, Kouichi Yoshinari, Kenji Watanabe

Förderung

  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science

Zitieren

APA

Tsunematsu, Y., Ogata, Y., Niwa, K., Ogata, N., Kobayashi, S., Sato, M., Matsushita, T., Shizu, R., Yoshinari, K., Mori, M., Saito-Nakano, Y., Nozaki, T., & Watanabe, K. (2025). Generation of noncanonical fumagillin derivatives with a twisted cyclohexane conformation through engineered biosynthesis. Bioscience, Biotechnology, and Biochemistry. https://doi.org/10.1093/bbb/zbaf091

Vancouver

Tsunematsu Y, Ogata Y, Niwa K, Ogata N, Kobayashi S, Sato M, et al. Generation of noncanonical fumagillin derivatives with a twisted cyclohexane conformation through engineered biosynthesis. Bioscience, Biotechnology, and Biochemistry. 2025. doi:10.1093/bbb/zbaf091

BibTeX
@article{Tsunematsu2025,
  author = {Tsunematsu, Yuta and Ogata, Yuji and Niwa, Kanji and Ogata, Namiko and Kobayashi, Seiki and Sato, Michio and Matsushita, Takuma and Shizu, Ryota and Yoshinari, Kouichi and Mori, Mihoko and Saito-Nakano, Yumiko and Nozaki, Tomoyoshi and Watanabe, Kenji},
  title = {Generation of noncanonical fumagillin derivatives with a twisted cyclohexane conformation through engineered biosynthesis},
  journal = {Bioscience, Biotechnology, and Biochemistry},
  year = {2025},
  doi = {10.1093/bbb/zbaf091}
}
Kostenlos starten →